Akebia Therapeutics (AKBA) Short-term Investments (2013 - 2019)
Akebia Therapeutics' Short-term Investments came in at $245,000 for Q4 2019, down 99.9% from $216.75 million a year earlier and down 98.9% from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Short-term Investments (2013 - 2019) Analysis & Trends
Going back to Q4 2013, Akebia Therapeutics' Short-term Investments data covers 25 quarters.
- Short-term Investments carries a five-year compound annual growth rate of -68.3% (FY2014 to FY2019).
- Going back by year, Short-term Investments was $216.75 million in FY2018 (-12.5%), $247.64 million in FY2017 (+239.2%), $73.01 million in FY2016 (-17.7%) and $88.68 million in FY2015 (+16.5%).
- The Q4 2019 figure represents the lowest quarterly Short-term Investments in data going back to Q4 2013.
- Year-over-year, Short-term Investments has declined for six consecutive quarters, with an average decline of 34.7% over the last eight quarters.
- The fastest year-over-year change in Short-term Investments over five years came in Q4 2017 (growth of 239.2%), and the weakest in Q4 2019 (a decline of 99.9%).
- Business Quant data shows AKBA's Short-term Investments at $22.73 million (Q3 2019), $49.55 million (Q2 2019) and $105.3 million (Q1 2019) in the three quarters before Q4 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn |
| 10 | Akebia Therapeutics | 236.42 Mn | -433.06 Mn | 38.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2019 | 245,000.00 |
| Sep 30, 2019 | 22.73 Mn |
| Jun 30, 2019 | 49.55 Mn |
| Mar 31, 2019 | 105.30 Mn |
| Dec 31, 2018 | 216.75 Mn |
| Sep 30, 2018 | 227.71 Mn |
| Jun 30, 2018 | 238.60 Mn |
| Mar 31, 2018 | 234.86 Mn |
| Dec 31, 2017 | 247.64 Mn |
| Sep 30, 2017 | 240.11 Mn |
| Jun 30, 2017 | 195.83 Mn |
| Mar 31, 2017 | 164.56 Mn |
| Dec 31, 2016 | 73.01 Mn |
| Sep 30, 2016 | 95.49 Mn |
| Jun 30, 2016 | 142.47 Mn |
| Mar 31, 2016 | 173.59 Mn |
| Dec 31, 2015 | 88.68 Mn |
| Sep 30, 2015 | 90.75 Mn |
| Jun 30, 2015 | 76.54 Mn |
| Mar 31, 2015 | 72.45 Mn |
API Access
Akebia Therapeutics Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();